Fat-Free mass, Not Just Weight, Predicts Long-Term Brain Advancement in Premature Infants
Table of Contents
A new study reveals that the quality of early growth, not just weight gain, considerably influences the long-term brain development of extremely preterm infants, highlighting fat-free mass (FFM) as a crucial marker of early developmental health.
Researchers publishing in the journal Pediatric Research in February 2025 have demonstrated a strong link between higher FFM in infancy and improved neurodevelopmental outcomes up to age three. This finding suggests that monitoring FFM could revolutionize nutritional care for vulnerable preterm infants.
Premature birth frequently enough leads to growth and nutritional deficiencies that can profoundly impact brain development. “Adequate early nutrition is crucial for optimal neurodevelopment,” researchers noted,”however,defining effective nutritional strategies remains challenging.”
Beyond Weight: The Importance of Body Composition
Traditionally, weight gain has been the primary indicator of an infant’s nutritional status. However, this study underscores the limitations of relying solely on weight. Recent technological advancements, such as air displacement plethysmography, now allow for a more precise assessment of body composition, differentiating between FFM – which encompasses muscle, organs, and brain tissue – and fat mass (FM). FFM is increasingly recognized as a more meaningful indicator of nutritional quality and overall organ growth.
Study Details and Key Findings
The study, conducted at a hospital in Vienna, followed 105 infants born before 28 weeks’ gestation. Researchers measured body composition at term-equivalent age, excluding infants with certain complications like severe brain bleeds or congenital abnormalities. The results revealed a compelling correlation: children with higher FFM demonstrated better performance on Bayley Scales of Infant Development, Third Edition (Bayley-III), a standardized assessment of cognitive, language, and motor skills, up to the age of three.
Specifically, the data showed that each one standard deviation increase in FFM corresponded to roughly a four-point enhancement in Bayley-III scores. Notably, fat mass and conventional growth measures like weight and head circumference did not show the same autonomous association with neurodevelopmental outcomes.
The impact of Nutritional Strategies
The research also highlighted the potential downsides of prolonged parenteral nutrition – intravenous feeding. A longer duration of parenteral nutrition was independently associated with poorer motor and language scores, notably at two and three years of age, suggesting potential adverse effects on nutritional or metabolic processes.
“This study found that FFM at term-equivalent age was an independent predictor of better cognitive, language, and motor development,” researchers concluded. This finding emphasizes that qualitative growth – the building of lean tissue – is more critical than simply achieving a certain weight.
Future Directions and Clinical Implications
While the study’s observational design prevents definitive conclusions about cause and effect, the findings strongly support the need for individualized nutritional strategies aimed at maximizing FFM gains in preterm infants. Researchers advocate for future randomized trials to test targeted nutritional interventions designed to enhance FFM.
The study’s strengths include its large, homogeneous cohort, high follow-up rate, and standardized assessments. Limitations include the lack of detailed nutritional intake data.Though, the research provides compelling evidence for the use of routine body composition monitoring as a clinical tool to guide tailored nutrition and possibly improve neurodevelopmental outcomes in this vulnerable population. .
Journal reference: Binder, C.,Calek,E., Thajer, A.,Harreiter,K., Longford, N., Fuiko, R., Berger, A., Goeral, K. (2025). Fat-free mass is associated with neurodevelopment outcomes in extremely preterm infants up to 3 years of age. Pediatric Research. DOI: 10.1038/s41390-025-04557-1, https://www.nature.com/articles/s41390-025-04557-1
